*** For details on how to be removed from this list visit the *** *** CCP4 home page http://www.ccp4.ac.uk ***
Position available: Post-doctoral Fellowship in Protein Crystallography Structural Genomics Consortium Karolinska Institutet Stockholm Sweden Suitable candidates will have a PhD in a relevant area of Structural Biology with extensive experience in most aspects of protein crystallography (including crystallisation, synchrotron data collection, structure solution and refinement). Candidates are expected to be team players and have a strong publication record. Practical experience in structural genomics is a definite advantage The successful candidate will be responsible for the structure determination of targets from SGC Stockholm target list and to assist in the running of the Xray crystallography lab which includes a crystallisation robot, plate hotels and crystal imaging systems, micro- focus rotating anode Xray generator, CCD Xray detector and automatic sample changer. The position is a temporary project position until Dec 31 2007. The position however may be extended should the project receive additional funding. General requirements to be eligible for this position are: I. Non-Swedish citizenship and II. Doctoral degree from a University outside Sweden. Starting date: Jan/Feb 2006 For further information contact: Dr. Derek Ogg, (Email: [EMAIL PROTECTED], Tel: +46 8 524 868 43) Please send your application (C.V and covering letter) to: Dr. Derek Ogg, Structural Genomics Consortium Karolinska Institutet, Scheelesvägen 2 171 77 Stockholm Sweden. A list of at least two reference persons should be included. Application deadline: Thursday 01-12-2005 ---------------------------------------------------------------------------- The Structural Genomics Consortium (SGC) is a not-for-profit organization that aims to determine the three dimensional structures of proteins of medical relevance, and place them in the public domain without restriction. The initiative was launched in Oxford and Toronto in April 2003 with funding from Canadian and British sponsors from both the public and private sectors (The Wellcome Trust, GlaxoSmithKline, Genome Canada, the Ontario Research and Development Challenge Fund, the Ontario Innovation Trust and the Canadian Institutes of Health Research). In 2005, a consortium of Swedish sponsors (VINNOVA, SSF, KAW and KI) provided funds to the SGC and a Swedish node was launched at the Karolinska Institutet. The goal of the SGC is to develop the infrastructure and technologies necessary for rapid, parallel structure determination, with the aim of having the capability to determine more than 200 protein structures per year. Over the first three years, the SGC is targeting 400 proteins that have relevance to human health and disease, such as proteins associated with diabetes, cancer, and infectious diseases such as malaria. Targets are also chosen based on interest from the academic and pharmaceutical communities, expertise within the Consortium and scientific impact.
